Delivery Order SPE2DB20D3103-SPE2DB25FM3F7
Award Date
1/14/25
Potential Completion Date
2/5/25
Potential Value
$96K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ZEPZELCA 4 MG VIALS. The $9,025.76 firm-fixed-price delivery order has a completion date of November 26, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical...
This federal contract award, valued at $9,565.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPZELCA 4 MG VIALS, a pharmaceutical product, with a completion date of January 30, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,337.72 firm-fixed-price delivery order is for the supply of ZEPZELCA 4 MG VIALS, a specialized pharmaceutical product. The contract has an ultimate completion date of December 31, 2024 and was awarded on December 9, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,565.56, is for the delivery of ZEPZELCA 4 MG VIALS, a specialty medication. The contract has an ultimate completion date of February 12, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The $9,025.76 firm fixed price delivery order is for the supply of Zepzelca 4 mg vials, a specialty pharmaceutical product. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for...
This federal contract award to Amerisourcebergen Drug Corp (DUNS: TGxsdkVQRGhOYUpNR001SFhYRURNdz09) was issued by the Defense Logistics Agency (DLA) for the delivery of Zepzelca 4 mg vials, a specialty pharmaceutical product. The $35,563.44 firm fixed-price delivery order has an ultimate completion date of August 21, 2023 and was awarded on July 31, 2023. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The $9,025.76 Firm Fixed Price contract is for the supply of 4,565,122,173 units of the drug ZEPZELCA 4 MG VIALS. This award is part of a larger Indefinite Delivery Contract between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $9,025.76 firm fixed price delivery order is for the supply of 4 mg vials of the cancer drug Zepzelca. The award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $9,025.76 Firm Fixed Price Delivery Order is for the supply of Zepzelca 4 mg vials, a prescription medication. The award is not associated with a set-aside program and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Zepzelca 4 mg vials, a specialty medication. The contract has a ceiling value of $28,696.68 and a period of performance through February 20, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and has an extensive Indefinite...